Skip to main content
Alteogen Inc. logo

Alteogen Inc. — Investor Relations & Filings

Ticker · 196170 ISIN · KR7196170005 KO Professional, scientific and technical activities
Open in API
Filings indexed 293 across all filing types
Latest filing 2021-03-29 Declaration of Voting R…
Country KR South Korea
Listing KO 196170

About Alteogen Inc.

http://www.alteogen.com/

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM) for Alteogen, dated 2021-03-29. It details the approval of financial statements, dividend resolutions, and the election of directors and auditors. This falls under the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the specific outcomes of shareholder votes.
2021-03-29 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company Alteogen. It provides specific details such as the reference price and the effective date. This type of corporate action announcement regarding capital changes fits the 'Share Issue/Capital Change' category.
2021-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by Alteogen. It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and auditor information. While it contains financial data, it is a regulatory disclosure announcing the completion and submission of the audit report to the exchange, rather than the full annual report itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2020
2021-03-19 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Alteogen, covering the fiscal year 2020. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is not a standalone 'Annual Report' (10-K) as it focuses specifically on the audit and financial statements, and it is not a short announcement. Therefore, it is classified as an Audit Report. FY 2020
2021-03-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items, and proxy voting procedures. While it includes financial statements, these are provided as supporting information for the AGM agenda, not as a standalone financial report. Therefore, it is classified as Proxy Solicitation & Information Statement.
2021-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Alteogen. It details the date, location, and specific agenda items (proposals) for the upcoming meeting, including the election of directors, auditors, and approval of financial statements. This type of document is a standard proxy solicitation material used to inform shareholders of upcoming votes and request their participation, which falls under the Proxy Solicitation & Information Statement category.
2021-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.